SARS-CoV-2 infection: The role of cytokines in COVID-19 disease

被引：725

作者：

Costela-Ruiz, Victor J. ^{[1
,2
]}

Illescas-Montes, Rebeca ^{[1
,2
]}

Puerta-Puerta, Jose M. ^{[3
]}

Ruiz, Concepcion ^{[1
,2
,4
]}

Melguizo-Rodriguez, Lucia ^{[1
,2
]}

机构：

[1] Univ Granada, Fac Hlth Sci, Dept Nursing, Biomed Grp BIO277, Avda Ilustrac 60, Granada 18016, Spain

[2] Ibs Granada, Inst Biosanit Res, C Doctor Asspitarte 4,4a Planta, Granada 18012, Spain

[3] Univ Hosp Virgen de las Nieves, Hematol & Hemotherapy Unit, Granada, Spain

[4] Univ Granada, Inst Neurosci, Ctr Invest Biomed CIBM, Parque Tecnol Salud PTS Avda Conocimiento S-N, Granada 18016, Spain

来源：

CYTOKINE & GROWTH FACTOR REVIEWS | 2020年 / 54卷

关键词：

COVID-19; SARS-CoV-2; Chemokines; Growth factors; Cytokine storm; COLONY-STIMULATING FACTOR; MESSENGER-RNA EXPRESSION; SARS-CORONAVIRUS; GM-CSF; INTERFERON-GAMMA; DENDRITIC CELLS; INTERLEUKIN-3; IL-3; FETAL MONOCYTES; VIRAL-INFECTION; GROWTH-FACTOR;

D O I：

10.1016/j.cytogfr.2020.06.001

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

COVID-19 disease, caused by infection with SARS-CoV-2, is related to a series of physiopathological mechanisms that mobilize a wide variety of biomolecules, mainly immunological in nature. In the most severe cases, the prognosis can be markedly worsened by the hyperproduction of mainly proinflammatory cytokines, such as IL-1, IL-6, IL-12, IFN-gamma, and TNF-alpha, preferentially targeting lung tissue. This study reviews published data on alterations in the expression of different cytokines in patients with COVID-19 who require admission to an intensive care unit. Data on the implication of cytokines in this disease and their effect on outcomes will support the design of more effective approaches to the management of COVID-19.

引用

页码：62 / 75

页数：14

共 50 条

[31] Is COVID-19 Infection a Multiorganic Disease? Focus on Extrapulmonary Involvement of SARS-CoV-2
Duloquin, Gauthier
Pommier, Thibaut
Georges, Marjolaine
Giroud, Maurice
Guenancia, Charles
Bejot, Yannick
Laurent, Gabriel
Rabec, Claudio
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
[32] Rehabilitation with coronavirus disease with SARS-CoV-2 (COVID-19)
Platz, Thomas
Dewey, Stefan
Koellner, Volker
Schlitt, Axel
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (15) : 981 - 988
[33] Rehabilitation with coronavirus disease with SARS-CoV-2 (COVID-19)
Platz, Thomas
Dewey, Stefan
Koellner, Volker
Schlitt, Axel
REHABILITATION, 2022, 61 (04) : 297 - 310
[34] Airborne transmission of SARS-CoV-2 disease (COVID-19)
Parvez, Mohammad K.
Parveen, Shama
FUTURE VIROLOGY, 2022, 17 (05) : 261 - 264
[35] Role of SARS-CoV-2 neurotropism and neuroinvasion in COVID-19 patients disease severity
Grijalva-Otero, Israel
GACETA MEDICA DE MEXICO, 2020, 156 (04): : 339 - 343
[36] Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)
Carrascosa, J. M.
Morillas, V
Bielsa, I
Munera-Campos, M.
ACTAS DERMO-SIFILIOGRAFICAS, 2020, 111 (09): : 734 - 742
[37] COVID-19(SARS-CoV-2 infection) in lymphoma patients: A review
Valentina Bonuomo
Isacco Ferrarini
Michele Dell’Eva
Eugenio Sbisà
Mauro Krampera
Carlo Visco
World Journal of Virology, 2021, (06) : 312 - 325
[38] Human genetics of SARS-CoV-2 infection and critical COVID-19
Mogensen, Trine H.
CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (11) : 1417 - 1421
[39] COVID-19 (SARS-CoV-2) Infection in Pregnancy: A Systematic Review
Akhtar, Hubba
Patel, Chandni
Abuelgasim, Eyad
Harky, Amer
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2020, 85 (04) : 295 - 306
[40] Pharmacological options in treating SARS-CoV-2 infection/COVID-19
Fabian Akos
Laszlo Istvan
Juhasz Marianna
Berhes Mariann
Vegh Tamas
Koszta Gyorgy
Molnar Csilla
Fulesdi Bela
ORVOSI HETILAP, 2020, 161 (17) : 685 - 688

← 1 2 3 4 5 →